Anavex Life Sciences (NASDAQ:AVXL) reported quarterly earnings results on February 09, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share…
Anavex Life Sciences (NASDAQ:AVXL) reported quarterly earnings results on February 09, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.06, beating the consensus estimate of $-0.11 by $0.05 per share. Revenue came in at , meeting the estimate of .
Anavex Life Sciences's stock moved following the earnings release. The stock currently trades at $4.15 with a market capitalization of $367.2M.
Current market data
NASDAQ · AVXL
$2.86
Up: +$0.01 · +0.35%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
sec_filing ·
sec_filing ·
sec_filing ·
earnings ·
